Master_of_Fine_Charts

XERS- A little consolidation before take off

做多
NASDAQ:XERS   Xeris Biopharma Holdings, Inc.
After bottoming out in early December at the 200 sma it has made higher lows and the 9ema crossed the 20 ema. In addition both EMAs crossed the 50 sma showing us that the short and medium term trends are bullish. This will bounce around a bit in the $5.70-$5.09 range as it builds a new base before moving to new highs. It will see some resistance at $6.33

First target $7.16
Second target $7.68
Third target $8.68
Final Destination $11.60

I am long XERS and consider it a buy and add for 2021

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。